


Gabather Email Formats
Pharmaceutical Manufacturing • Södertälje, Stockholm County, Sweden • 1-10 Employees
Key Contact at Gabather
Michael-Robin Witt
Chief Executive Officer
Company overview
| Headquarters | Forskargatan 20 J, Södertälje, Stockholm County 151 36, SE |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Keywords | Pharmaceuticals, Clinical Trials, Drug Discovery, Drug Development, Mild Cognitive Impairment, Phase 1, Cognition, Phase 2, Schizophrenia, Central Nervous System (Cns), Antidepressants, Affective Disorders, Gabaa Receptor Modulators |
| Founded | 2014 |
| Employees | 1-10 |
| Socials |
About Gabather
Gabather (abbreviated form of GABA Therapeutics) focuses on the development of highly potent and selective GABAA receptor modulators targeting the principal inhibitory neurotransmitter in the mammalian brain, gamma aminobutyric acid (GABA). Our drug development candidates are small molecular weight compounds designed through proprietary pharmacophore modelling. Our development pipeline includes candidates targeting the GABAA receptor in both preclinical and clinical development and we aim to produce novel pharmaceuticals such as antipsychotics, antidepressants, anxiolytics, analgesics and cognitive enhancers to treat CNS diseases with high unmet need.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Gabather has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Gabather has never raised funding before.
Gabather Tech Stack
Discover the technologies and tools that power Gabather's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
JavaScript graphics
JavaScript graphics
JavaScript libraries
Maps
Hosting
CDN
JavaScript libraries
Analytics
UI frameworks
JavaScript libraries
Frequently asked questions
4.8
40,000 users



